Oruka Therapeutics, Inc. Current Liabilities
Oruka Therapeutics, Inc. (ORKA) had Current Liabilities of $22.97 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities
us-gaap:LiabilitiesCurrent · last filed 2026-08-10
- 2026-06-30: Liabilities, Current $22.97M.
- 2026-03-31: Liabilities, Current $16.63M.
- 2025-12-31: Liabilities, Current $15.37M.
- 2025-09-30: Liabilities, Current $20.97M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $22.97M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $16.63M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $15.37M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $20.97M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $12.11M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $11.72M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $13.04M 10-K · filed 2026-03-12 |
| 2024-09-30 | $18.04M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $1.27M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $1.58M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $637.00K 10-Q · filed 2024-08-01 |
| 2023-09-30 | $992.00K 10-Q · filed 2023-10-18 |
| 2023-06-30 | $1.60M 10-Q · filed 2023-07-21 |
| 2023-03-31 | $1.27M 10-Q · filed 2023-04-24 |
| 2022-12-31 | $1.13M 10-K · filed 2024-02-01 |
| 2022-09-30 | $1.94M 10-Q · filed 2022-10-28 |
| 2022-06-30 | $2.81M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $2.72M 10-Q · filed 2022-05-02 |
| 2021-12-31 | $3.50M 10-K · filed 2023-02-24 |
| 2021-09-30 | $3.18M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $3.69M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $2.88M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $3.50M 10-K · filed 2022-03-14 |
| 2020-09-30 | $1.53M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $1.33M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $1.16M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $926.00K 10-K · filed 2021-03-18 |
| 2019-09-30 | $1.15M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $1.20M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $1.29M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $793.00K 10-K · filed 2020-02-18 |
| 2018-09-30 | $978.00K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $1.06M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $1.72M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $2.07M 10-K · filed 2019-02-27 |
| 2017-09-30 | $2.54M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $2.52M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $2.52M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $2.40M 10-K · filed 2018-03-22 |
| 2016-09-30 | $2.16M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $1.70M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $2.34M 10-Q · filed 2016-05-11 |
| 2015-12-31 | $1.50M 10-K · filed 2017-03-21 |
| 2015-09-30 | $1.30M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $1.36M 10-Q · filed 2015-08-11 |
| 2015-03-31 | $1.13M 10-Q · filed 2015-05-12 |
| 2014-12-31 | $1.39M 10-K · filed 2016-03-17 |
| 2014-09-30 | $838.00K 10-Q · filed 2014-11-12 |
| 2014-06-30 | $1.22M 10-Q · filed 2014-08-13 |
| 2014-03-31 | $1.12M 10-Q · filed 2014-05-13 |
| 2013-12-31 | $1.50M 10-K · filed 2015-03-19 |
| 2013-09-30 | $769.00K 10-Q · filed 2013-11-13 |
| 2013-06-30 | $750.00K 10-Q · filed 2013-08-13 |
| 2013-03-31 | $828.00K 10-Q · filed 2013-05-13 |
| 2012-12-31 | $305.00K 10-K · filed 2014-03-20 |
| 2012-09-30 | $286.00K 10-Q · filed 2012-11-13 |
| 2012-06-30 | $529.00K 10-Q · filed 2012-08-13 |
| 2012-03-31 | $594.00K 10-Q · filed 2012-05-14 |
| 2011-12-31 | $754.00K 10-K · filed 2013-03-21 |
| 2011-09-30 | $661.00K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $1.00M 10-Q · filed 2011-08-15 |
| 2010-12-31 | $1.19M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |